Two of the six vouchers in the second round went to GLP-1 drugs: Novo Nordisks semaglutide, directed toward a higher-dose formulation of Wegovy, and Eli Lillys orforglipron, an oral non-peptide small molecule that had not yet received FDA approval
Subsequently, each system underwent independent simulations lasting 500 ns each (totaling 1.5 s per system) at 298 K, employing the Langevin thermostat with a time step of 0.2 fs (Supplementary Fig
R2 : Starting dose is 1.5mg daily for 30 days, then increase to 4 mg (days 3160)
BEAM Bulls-eye chart highlighting the R&D landscape for GLP-1 drugs
Physical Non-Scale Victories: How your clothes fit (even when weight hasnt changed) Sustained energy for extended physical activity Improved comfort in clothing sizes Reduced inflammation Better physical function overall Improved metabolic lab markers Mental and Emotional Benefits You May Experience: Freedom from food noise, the constant preoccupation with food that many patients dont fully recognize until it resolves Making food choices without persistent internal conflict Mental clarity and ease around eating decisions Improved overall mood These non-scale victories often tell you more about your progress than what the scale shows day to day
doi.org/10.1038/nature03000 Dalmasso, G., et al